In this study, our findings depict a region-specific TRPV4 increase in the brain endothelium around inflammatory MS lesions and suggest tumor necrosis factor alpha (TNFα) as one inducer for this enhanced expression. The gene discussed is TRPV4; the disease is myeloid sarcoma.